德康医疗Q2业绩超预期,上调全年营收指引的下限

格隆汇
Jul 31
连续血糖监测仪制造商德康医疗(DexCom)公布第二季度业绩,营收同比增长约13%至13.1亿美元,超过市场预期的12.9亿美元;调整后每股收益为0.70美元,亦超过市场预期的0.61美元。公司上调全年营收指引的下限,目前预计营收将介乎51.8亿至52.5亿美元,此前预期为51.6亿至52.5亿美元,市场预期为52.2亿美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10